vimarsana.com
Home
Live Updates
MindMed Collaborators Announce Positive Topline Data from Ph
MindMed Collaborators Announce Positive Topline Data from Ph
MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)
– Primary endpoint achieved statistically significant improvement in MDD symptoms –
– Confirmation of activity of lysergide in brain health disorders with direct relevance to... | April 14, 2023
Related Keywords
Switzerland ,
Canada ,
Canadian ,
Robert Barrow ,
Matthias Liechti ,
Felix Mueller ,
Medicine Mindmed Inc ,
University Hospital Basel ,
Nasdaq ,
Company Or Mindmed ,
Liechti Lab ,
University Hospital Of Psychiatry ,
Mind Medicine ,
University Hospital ,
Depressive Symptomatology ,
Chief Executive Officer ,
Initiated Clinical ,
Beck Depression Index ,
Mind Medicine Mindmed Stock Exchange ,
News ,
Information ,
Press Release ,
Primary ,
Ndpoint ,
Chieved ,
Statistically ,
Significant ,
Improvement ,
N ,
Odd ,
Symptoms ,
Confirmation ,
F ,
Activity ,
Ysergide ,
Rain ,
Health ,
Disorders ,
Ith ,
Direct ,
Elevance Mnmd Ca60255c8850 ,